Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Sanidad Militar
versión impresa ISSN 1887-8571
Resumen
APARICIO HERNANDEZ, R.; GARCIA LUQUE, A.; GONZALO SALADO, M.ªH. y CABANES MARISCAL, M.A.. Positive assessment of drugs: september/October/November 2015. Sanid. Mil. [online]. 2016, vol.72, n.1, pp.42-52. ISSN 1887-8571.
The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in September, October and November of 2015, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.
Palabras clave : Asparaginasa; Spectrila®; Blinatumomab; Blincyto®; Brivaracetam; Brivi®; Carfilzomib; Kyprolis®; Cobimetinib; Cotellic®; Efmoroctocog alfa; Elocta®; Elvitegravir/Cobicistat/Emtricitabina/Tenofovir Alafenamida; Genvoya®; Etanercept; Benepali®; Extracto de corteza de abedul; Episalvan®; Fenilbutirato de glycerol; Ravicti®; Fentanilo; Ionsys®; Idarucizumab; Praxbind®; Levodopa/carbidopa; Numient®; Lumacaftor/Ivacaftor; Orkambi®; Mepolizumab Nucala®; Pegaspargasa; Oncaspar®; Pitolisant; Wakix®; Sacubitril/Valsartan; Entresto®; Talimogene Laherparepvec; Imlygic®.